BlueRock Therapeutics
- Active openings
- 9
- US-based roles
- 4
- Remote-friendly
- 0
- Last updated
- 2026-09-10
What BlueRock Therapeutics is hiring for
Open positions
9 active- Senior Analyst, Analytical and Quality ControlToronto, CASep 10
- Associate Director, Vendor ManagementCambridge, MASep 9
- Associate Director, Translational Medicine and Nonclinical DevelopmentCambridge, MASep 4
- Senior Director, People Strategy and EngagementCambridge, MASep 3
- Analyst II, Analytical and Quality ControlToronto, CAAug 26
About BlueRock Therapeutics
Claim to unlockMission, culture, and benefits - visible once this page is claimed and verified.
Updates
FDA grants Orphan Drug Designation to BlueRock Therapeutics’ investigational cell therapy OpCT-001
BlueRock Therapeutics investigative cell therapy bemdaneprocel for treating Parkinson’s disease receives Pioneering Regenerative Medical Product designation in Japan
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease
First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational cell therapy bemdaneprocel
BlueRock Therapeutics announces first patient receives investigational therapy in Phase 1/2a clinical trial of OpCT-001 for the treatment of primary photoreceptor diseases
Forging the future of cell therapy: Bayer and BlueRock’s unique journey